• Register
  • Login

Current Journal of Neurology

  1. Home
  2. Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Peer Review Process

Journal Metrics

News

Publication Ethics and Malpractice Statement

Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.

Document Type : Special Articles

Author

  • Morteza Mahmoudi

Department of Nanotechnology AND Nanotechnology Research Center, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

#No Abstract#

Current Journal of Neurology
Volume 13, Issue 1 - Serial Number 58
March 2014
Pages 48-49
Files
  • XML
  • PDF 66.29 K
Share
How to cite
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 38
  • PDF Download: 22

APA

Mahmoudi, M. (2020). Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.. Current Journal of Neurology, 13(1), 48-49.

MLA

Morteza Mahmoudi. "Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.". Current Journal of Neurology, 13, 1, 2020, 48-49.

HARVARD

Mahmoudi, M. (2020). 'Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.', Current Journal of Neurology, 13(1), pp. 48-49.

VANCOUVER

Mahmoudi, M. Amyloid-based therapies did fail again! It is the right time to change our vision on building block of Alzheimer's disease.. Current Journal of Neurology, 2020; 13(1): 48-49.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

  • Scopus 2021-08-17

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 international license (http://creativecommons.org/licenses/bync/4.0/). Non-commercial purposes uses of the work are permitted, provided the original work is properly cited.

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by Sinaweb